NCT05906004

Brief Summary

This is a clinical investigation study. It will verify the long-term safety and performance of the Pitch-Patch when implanted to reinforce partially repairable rotator cuff tears and used as described by the manufacturer's instructions. The medical device in this study is already on the market and is manufactured by Xiros Ltd. The Pitch-Patch is a single-use polyester prosthesis available in two sizes (30x20mm and 35x25mm). It is reinforced around the perimeter and around each eyelet to provide strength and stability to the device and repair. The study will collect data on patients who meet the entry criteria and have received the device. This is a single-armed study, meaning all patients will have a Pitch-Patch. The total length of the study is expected to be 3 years. A minimum of 37 patients will be enrolled into the study. Patients will be enrolled at a study specific follow up visit 2-2.5 years after implant, and data for baseline, procedure, and other time points prior to 2 years (3month, 6month, and 1 year post surgery) will be collected retrospectively from medical records if available.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
42mo left

Started May 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Dec 2029

First Submitted

Initial submission to the registry

May 25, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
2.9 years until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2029

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

3.5 years

First QC Date

May 25, 2023

Last Update Submit

May 12, 2026

Conditions

Keywords

Rotator Cuff ReinforcementRotator Cuff RepairPitch-PatchXirosRotator Cuff Augmentation

Outcome Measures

Primary Outcomes (2)

  • Constant Murley Score (CMS)

    The primary performance endpoint is the change in the CMS from baseline (if available) and between post-surgery timepoints up to at least 2 years after surgery. CMS comprises of 4 parts: Pain reported by the patient (max 15 points), activities of daily living reported by patient (max 20 points), range of movement assess by the examiner (max 40 points), and strength assessed by the examiner (max 25 points). Scores range from 0 to 100. Better functioning shoulders will have a greater number of points, up to a maximum of 100 points.

    2 years

  • Device Related or Procedure Related Adverse Events

    Device related and/ or procedure related adverse events up to at least 2 years after surgery

    2 years

Secondary Outcomes (6)

  • Re-tear Rate

    2 years

  • Constant Murley Score (subscale)

    2 years

  • Normal Daily Work/ Normal Recreational Activities

    2 years

  • Tegner Score

    2 years

  • Subjective Shoulder Value

    2 years

  • +1 more secondary outcomes

Interventions

Pitch-Patch device used for rotator cuff augmentation/ reinforcement.

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Rotator cuff tear treated with Pitch-Patch for augmentation or reinforcement of the rotator cuff.

You may qualify if:

  • Patient has been treated using a Pitch-Patch device for augmentation or reinforcement of the rotator cuff 2-2.5years prior to enrolment.
  • Patient has a baseline Constant Murley Score (CMS), assessed within 30 days prior to implantation of the device.
  • Patient must be 16 years old or above.
  • Patient is willing to participate in the study, and having been informed of the nature of the study, has provided written informed consent as approved by the Ethics Committee (EC).

You may not qualify if:

  • \- The Pitch-Patch has been used outside its intended use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reading Shoulder Unit

Reading, RG1 6UZ, United Kingdom

RECRUITING

MeSH Terms

Conditions

Rotator Cuff Injuries

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

June 15, 2023

Study Start

May 1, 2026

Primary Completion (Estimated)

November 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

May 15, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations